Thiogenesis Therapeutics, Corp.
TTIPF
$0.44
$0.02897.03%
OTC PK
09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -15.47% | -10.98% | -23.87% | 99.59% | -23.43% |
Total Receivables | 56.32% | -50.71% | 9.29% | 92.84% | -5.90% |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -28.24% | -32.94% | -17.69% | 805.88% | 0.00% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | -14.91% | -11.91% | -23.41% | 101.27% | -23.21% |
|
|||||
Total Current Assets | -14.91% | -11.91% | -23.41% | 101.27% | -23.21% |
Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | -14.91% | -11.91% | -23.41% | 101.27% | -23.21% |
|
|||||
Total Accounts Payable | -65.22% | -11.43% | -79.88% | 433.90% | -10.33% |
Total Accrued Expenses | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
Total Other Current Liabilities | -- | -- | -- | -- | -- |
Total Current Liabilities | -65.22% | -11.43% | -80.38% | 447.49% | -10.33% |
|
|||||
Total Current Liabilities | -65.22% | -11.43% | -80.38% | 447.49% | -10.33% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | -65.22% | -11.43% | -80.38% | 447.49% | -10.33% |
|
|||||
Common Stock & APIC | 1.39% | -1.06% | 1.73% | 22.32% | -1.40% |
Retained Earnings | -6.63% | -4.38% | -3.75% | -24.43% | -10.61% |
Treasury Stock & Other | 3.57% | 3.05% | -9.68% | 4,984.44% | -119.66% |
Total Common Equity | -11.64% | -11.94% | -5.77% | 68.31% | -24.24% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -11.64% | -11.94% | -5.77% | 68.31% | -24.24% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -11.64% | -11.94% | -5.77% | 68.31% | -24.24% |
|